Administration of a glypican‐3 peptide increases the infiltration and cytotoxicity of <scp>CD8</scp><sup>+</sup> T cells against testicular yolk sac tumor, associated with enhancing the intratumoral <scp>cGAS</scp>/<scp>STING</scp> signaling
Cancer medicine